Published in J Virol on October 01, 2003
The molecular biology of human herpesvirus-6 latency and telomere integration. Microbes Infect (2011) 0.91
The DR1 and DR6 first exons of human herpesvirus 6A are not required for virus replication in culture and are deleted in virus stocks that replicate well in T-cell lines. J Virol (2010) 0.84
Novel gene therapy viral vector using non-oncogenic lymphotropic herpesvirus. PLoS One (2013) 0.75
Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol (1990) 16.31
Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci U S A (1997) 5.37
Promoter-regulatory region of the major immediate early gene of human cytomegalovirus. Proc Natl Acad Sci U S A (1984) 5.04
The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology (1995) 4.77
Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol (1991) 4.61
Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell (1997) 3.99
A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis. Proc Natl Acad Sci U S A (2000) 3.45
A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc Natl Acad Sci U S A (1999) 3.22
Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci U S A (1994) 3.03
Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci U S A (1996) 2.87
A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci U S A (2001) 2.80
Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J Virol (1999) 2.42
Determination and analysis of the complete nucleotide sequence of human herpesvirus. J Virol (1996) 2.37
Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J Virol (1994) 2.31
Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. J Infect Dis (1990) 2.08
Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol (1991) 2.05
Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis. J Virol (2003) 2.03
Human herpesvirus 6. Clin Microbiol Rev (1997) 1.91
Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B. J Virol (1999) 1.76
Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice. Virology (1995) 1.44
Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals. J Clin Microbiol (1993) 1.42
Human herpesvirus 6: An emerging pathogen. Emerg Infect Dis (1999) 1.33
Association of human herpesvirus 6 infection of the central nervous system with recurrence of febrile convulsions. J Infect Dis (1993) 1.26
Products of US22 genes M140 and M141 confer efficient replication of murine cytomegalovirus in macrophages and spleen. J Virol (2001) 1.14
Recombinant cytomegaloviruses for study of replication and pathogenesis. Intervirology (1996) 1.05
Human herpesvirus 6 open reading frame U83 encodes a functional chemokine. J Virol (1999) 1.04
Establishment of titration system for human herpesvirus 6 and evaluation of neutralizing antibody response to the virus. J Clin Microbiol (1989) 1.02
CD68+ cells of monocyte/macrophage lineage in the environment of AIDS-associated and classic-sporadic Kaposi sarcoma are singly or doubly infected with human herpesviruses 7 and 6B. Proc Natl Acad Sci U S A (1997) 1.01
Analysis of a glycoprotein of human herpesvirus 6 (HHV-6) using monoclonal antibodies. Virology (1990) 1.00
Human herpesvirus 6. Clin Infect Dis (2001) 0.99
Analysis of human herpesvirus 6 U3 gene, which is a positional homolog of human cytomegalovirus UL 24 gene. Virology (1998) 0.97
Identification of human herpesvirus 6 latency-associated transcripts. J Virol (2002) 0.91
Human herpesvirus 6 DNA in blood cells of human immunodeficiency virus-infected men: correlation of high levels with high CD4 cell counts. J Infect Dis (1994) 0.91
Characterisation of a human herpesvirus 6 variant A 'amplicon' and replication modulation by U94-Rep 'latency gene'. J Virol Methods (2002) 0.80
Recognition of a novel stage of betaherpesvirus latency in human herpesvirus 6. J Virol (2003) 0.79
SOCS-1 participates in negative regulation of LPS responses. Immunity (2002) 3.39
Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J Virol (2002) 2.05
Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals. J Infect Dis (2009) 1.60
The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J Infect Dis (2002) 1.58
Age-dependent changes in the incidence and etiology of childhood thrombocytosis. Acta Haematol (2004) 1.56
Human herpesvirus 6B infection of the large intestine of patients with diarrhea. Clin Infect Dis (2002) 1.40
Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46. J Virol (2004) 1.37
Human herpesvirus 6 (HHV-6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA. J Med Virol (2004) 1.36
Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46. J Virol (2003) 1.34
Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen. J Virol (2004) 1.34
Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol (2013) 1.33
Human herpesvirus 6 variant A but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46. J Virol (2002) 1.31
Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway. Traffic (2008) 1.31
Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli. Vaccine (2004) 1.27
Intracellular processing of human herpesvirus 6 glycoproteins Q1 and Q2 into tetrameric complexes expressed on the viral envelope. J Virol (2004) 1.20
High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood (2002) 1.17
Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors. Hum Gene Ther (2007) 1.13
Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction. Stem Cells (2009) 1.12
The human herpesvirus 6 U100 gene product is the third component of the gH-gL glycoprotein complex on the viral envelope. J Virol (2003) 1.08
Activation of human herpesvirus 8 open reading frame K5 independent of ORF50 expression. Virus Res (2002) 1.07
Human herpesvirus-6 rep/U94 gene product has single-stranded DNA-binding activity. J Gen Virol (2002) 1.07
Human herpesvirus 6 encoded glycoprotein Q1 gene is essential for virus growth. Virology (2010) 1.07
Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency. J Virol (2004) 1.05
CD134 is a cellular receptor specific for human herpesvirus-6B entry. Proc Natl Acad Sci U S A (2013) 1.04
Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus. J Virol (2006) 1.01
Human herpesvirus 6 glycoprotein complex formation is required for folding and trafficking of the gH/gL/gQ1/gQ2 complex and its cellular receptor binding. J Virol (2011) 1.00
Deletion in open reading frame 49 of varicella-zoster virus reduces virus growth in human malignant melanoma cells but not in human embryonic fibroblasts. J Virol (2007) 0.96
Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus. Vaccine (2007) 0.95
Human herpesvirus 6 open reading frame U14 protein and cellular p53 interact with each other and are contained in the virion. J Virol (2005) 0.95
Varicella-zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell-to-cell spread. J Virol (2007) 0.94
Human herpesvirus 6 envelope cholesterol is required for virus entry. J Gen Virol (2006) 0.92
Identification of human herpesvirus 6 latency-associated transcripts. J Virol (2002) 0.91
Real-time PCR determination of human herpesvirus 6 antiviral drug susceptibility. J Virol Methods (2006) 0.91
Analysis of a neutralizing antibody for human herpesvirus 6B reveals a role for glycoprotein Q1 in viral entry. J Virol (2011) 0.91
Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-gamma enzyme-linked immunospot assay. J Infect Dis (2008) 0.91
Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay. Vaccine (2003) 0.91
Characterization of varicella-zoster virus-encoded ORF0 gene--comparison of parental and vaccine strains. Virology (2010) 0.90
Efficient adenovirus vector-mediated PPAR gamma gene transfer into mouse embryoid bodies promotes adipocyte differentiation. J Gene Med (2008) 0.90
A posttranscriptional regulator of Kaposi's sarcoma-associated herpesvirus interacts with RNA-binding protein PCBP1 and controls gene expression through the IRES. Virology (2004) 0.90
Productive human herpesvirus 6 infection causes aberrant accumulation of p53 and prevents apoptosis. J Gen Virol (2004) 0.89
Pathogenetic tropism of varicella-zoster virus to primary human hepatocytes and attenuating tropism of Oka varicella vaccine strain to neonatal dermal fibroblasts. J Infect Dis (2003) 0.89
Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice. Vaccine (2009) 0.88
Role of dendritic cells infected with human herpesvirus 6 in virus transmission to CD4(+) T cells. Virology (2009) 0.87
Human herpesvirus 7 U47 gene products are glycoproteins expressed in virions and associate with glycoprotein H. J Gen Virol (2006) 0.87
Development of varicella vaccine. J Infect Dis (2008) 0.87
Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine. Vaccine (2007) 0.86
Intranasal immunization with a formalin-inactivated human influenza A virus whole-virion vaccine alone and intranasal immunization with a split-virion vaccine with mucosal adjuvants show similar levels of cross-protection. Clin Vaccine Immunol (2012) 0.86
Complementation of the function of glycoprotein H of human herpesvirus 6 variant A by glycoprotein H of variant B in the virus life cycle. J Virol (2012) 0.86
Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study. J Epidemiol (2015) 0.86
Efficient osteoblast differentiation from mouse bone marrow stromal cells with polylysin-modified adenovirus vectors. Biochem Biophys Res Commun (2008) 0.85
Strong interaction between human herpesvirus 6 and peripheral blood monocytes/macrophages during acute infection. J Med Virol (2002) 0.85
A community-based survey of varicella-zoster virus-specific immune responses in the elderly. J Clin Virol (2012) 0.85
Single dose of inactivated Japanese encephalitis vaccine with poly(gamma-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus. Vaccine (2007) 0.84
Human interleukin-6 induces human herpesvirus-8 replication in a body cavity-based lymphoma cell line. J Med Virol (2002) 0.84
Human herpesvirus 7 open reading frame U12 encodes a functional beta-chemokine receptor. J Virol (2003) 0.84
Human herpesvirus 7 open reading frames U12 and U51 encode functional beta-chemokine receptors. J Virol (2005) 0.84
Human herpesvirus-6 infection induces the reorganization of membrane microdomains in target cells, which are required for virus entry. Virology (2008) 0.84
DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine. Vaccine (2008) 0.84
The seroprevalence of human herpesvirus 8 infection in the Thai population. Southeast Asian J Trop Med Public Health (2002) 0.82
Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer's disease. Biochem Biophys Res Commun (2012) 0.82
Human herpesvirus 6 ganciclovir-resistant strain with amino acid substitutions associated with the death of an allogeneic stem cell transplant recipient. J Clin Virol (2008) 0.82
A viral transcriptional activator of Kaposi's sarcoma-associated herpesvirus (KSHV) induces apoptosis, which is blocked in KSHV-infected cells. Virology (2003) 0.81
Varicella-zoster virus ORF49 functions in the efficient production of progeny virus through its interaction with essential tegument protein ORF44. J Virol (2013) 0.81
Comparison of the cross-reactive anti-influenza neutralizing activity of polymeric and monomeric IgA monoclonal antibodies. Viral Immunol (2012) 0.80
Immune reactivity of human sera to the glycoprotein B of human herpesvirus 7. J Clin Microbiol (2002) 0.80
Poly-γ-glutamic acid nanoparticles and aluminum adjuvant used as an adjuvant with a single dose of Japanese encephalitis virus-like particles provide effective protection from Japanese encephalitis virus. Clin Vaccine Immunol (2011) 0.80
Highlights from 5th International Conference on HHV-6 and -7. Herpes (2006) 0.80
Mechanism of host cell protection from complement in murine cytomegalovirus (CMV) infection: identification of a CMV-responsive element in the CD46 promoter region. Eur J Immunol (2002) 0.79
y Human herpesvirus 6 envelope components enriched in lipid rafts: evidence for virion-associated lipid rafts. Virol J (2009) 0.79
Varicella-zoster virus ORF 58 gene is dispensable for viral replication in cell culture. Virol J (2008) 0.79
Varicella-zoster virus ORF1 gene product is a tail-anchored membrane protein localized to plasma membrane and trans-Golgi network in infected cells. Virology (2008) 0.79
Rapid and efficient introduction of a foreign gene into bacterial artificial chromosome-cloned varicella vaccine by Tn7-mediated site-specific transposition. Virology (2010) 0.79
Recognition of a novel stage of betaherpesvirus latency in human herpesvirus 6. J Virol (2003) 0.79
Human herpesvirus 6 immediate-early 2 protein interacts with heterogeneous ribonucleoprotein K and casein kinase 2. Microbiol Immunol (2004) 0.79
Characterization of the varicella-zoster virus ORF50 gene, which encodes glycoprotein M. J Virol (2010) 0.79
Identification of the human herpesvirus 6A gQ1 domain essential for its functional conformation. J Virol (2013) 0.78
Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine. AAPS PharmSciTech (2013) 0.78
Human herpesvirus 6 glycoprotein M is essential for virus growth and requires glycoprotein N for its maturation. Virology (2012) 0.78
An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain. J Dermatol Sci (2012) 0.78
Human herpesvirus 7 infection increases the expression levels of CD46 and CD59 in target cells. J Gen Virol (2007) 0.78
Influenza virus neuraminidase contributes to the dextran sulfate-dependent suppressive replication of some influenza A virus strains. Antiviral Res (2012) 0.78
Human herpesvirus-6 infection in neonates: Not protected by only humoral immunity. Pediatr Int (2002) 0.77
Reciprocal roles of cellular chemokine receptors and human herpesvirus 7-encoded chemokine receptors, U12 and U51. J Gen Virol (2007) 0.77
Human herpesvirus 6-associated hemophagocytic syndrome in a healthy adult. Emerg Infect Dis (2002) 0.77
Novel polyvalent live vaccine against varicella-zoster and mumps virus infections. Microbiol Immunol (2013) 0.77
Thrombopoietin in the cerebrospinal fluid of patients with aseptic and bacterial meningitis. J Interferon Cytokine Res (2005) 0.77
The Shozu Herpes Zoster (SHEZ) study: rationale, design, and description of a prospective cohort study. J Epidemiol (2012) 0.77
Genetic variations of human herpesvirus 7 by analysis of glycoproteins B and H, and R2-repeat regions. J Med Virol (2002) 0.76
Human herpesvirus 6 major immediate early promoter has strong activity in T cells and is useful for heterologous gene expression. Virol J (2011) 0.76
Acute myocardial infarction after Kawasaki disease in an infant: treatment with coronary artery bypass grafting. Pediatr Int (2009) 0.76
An MDCK cell culture-derived formalin-inactivated influenza virus whole-virion vaccine from an influenza virus library confers cross-protective immunity by intranasal administration in mice. Clin Vaccine Immunol (2013) 0.75
Novel gene therapy viral vector using non-oncogenic lymphotropic herpesvirus. PLoS One (2013) 0.75
Steinert's disease. BMJ Case Rep (2013) 0.75
Novel monoclonal antibodies for identification of multicentric Castleman's disease; Kaposi's sarcoma-associated herpesvirus-encoded vMIP-I and vMIP-II. Virology (2012) 0.75
Acute lymphoblastic leukemia with coexpression of CD56 and CD57: case report. Pediatr Hematol Oncol (2004) 0.75